Avricore Health Inc.
AVCR.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -93.15% | -70.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -93.15% | -70.21% | |||
| Cost of Revenue | -9.31% | -89.69% | |||
| Gross Profit | -114.42% | -42.74% | |||
| SG&A Expenses | 0.90% | -20.14% | |||
| Depreciation & Amortization | 0.00% | 14.29% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.89% | -63.38% | |||
| Operating Income | -592.98% | -177.30% | |||
| Income Before Tax | -515.58% | 89.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -515.58% | 89.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -515.58% | 89.41% | |||
| EBIT | -592.98% | -177.30% | |||
| EBITDA | -1,391.92% | -114.22% | |||
| EPS Basic | -560.00% | 90.00% | |||
| Normalized Basic EPS | -566.67% | -175.00% | |||
| EPS Diluted | -560.00% | 93.24% | |||
| Normalized Diluted EPS | -566.67% | -175.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||